Senior Director, Field Market Access

Benefits

Parental leave

Not verified

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Not verified checked Jun 13, 2026

Salary

$265K-$300K From the posting source checked Jun 20, 2026

401(k) match

Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$57,704 U.S. median for this role

Projected growth (BLS Employment Projections)

+0.9% - Slower

U.S. benchmark only; posted salary is not compared across countries or currencies.

Matched to SOC 41-2031 - Sales aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Sales From the posting source checked Jun 20, 2026

Seniority

Director Plus From the posting source checked Jun 20, 2026

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Company stage

Public-company From the posting source checked Jun 20, 2026

Equity

Offered Verified - SEC 10-K source checked Jun 20, 2026

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Senior Director, Field Market Access Field Based Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been submitted to the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-3050, an IND-cleared FAP-targeted radiotherapy; and IM-1617, an IND-cleared solid tumor ADC. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets. Position Overview Immunome is hiring a Senior Director, Field Market Access to lead U.S. field market access strategy and payer/provider engagement in support of launch readiness for varegacestat and our future oncology portfolio. This leader will translate brand strategy, clinical and economic evidence, and payer insights into an actionable field engagement model-partnering cross-functionally to remove access barriers and enable appropriate use. The role is expected to lead, and potentially build, a high-performing Field Market Access team and external partner ecosystem, operating as a hands-on, compliant, executive presence with national and regional stakeholders. Responsibilities Strategic responsibilities - Set field market access strategy aligned to launch/brand objectives, including coverage priorities and account segmentation, payer landscape assessment, payer education, policy and pathway planning, pull-through model design, and field playbooks across national/regional payers, PBMs, and organized provider systems. - Play a key role in shaping the payer and provider

Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.